Lianhuan Pharmaceutical (600513)
Overview
Jiangsu Lianhuan Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceuticals, preparations, and active pharmaceutical ingredients (API) products in China and internationally. The company offers clopidogrel bisulfate tablets, doxycycline hydrochloride, azithromycin, milrinone, dapoxetine hydrochloride, tadalafil, and betasine besylate tablets, as well as aprilite, danazol suppositories, and terfenadine tablets. It also provides urinary system drugs, including
Employees2131
Market Cap$4.9B
Revenue$2.9B
Listed OnShanghai Stock Exchange
Ticker600513
CEOMr. Zhen Hua Qian
HeadquartersYangzhou